Skip to main content

Table 1 Detection and efficiency of CRISPR/Cas9-mediated indel mutation at Ramp2 locus at blastocyst stage

From: A single blastocyst assay optimized for detecting CRISPR/Cas9 system-induced indel mutations in mice

Experiment no.

Site injected1

Cas9 mRNA: R2 gRNA (ng/μL)

No. zygotes injected

No. blastocysts/no. zygotes cultures (%)

No. mutant blastocysts/no. blastocysts tested (%)2

1

cyto

100:50

25

19/21 (90)

6/21 (32)

2

pn/cyto

100:50

15

8/10 (80)

2/8 (25)

3

pn/cyto

200:50

24

8/17 (47)

8/8 (100)3

  1. 1Injection was performed toward cyto: cytoplasm; pn/cyto pronuclei and cytoplasm.
  2. 2Mutated blastocysts were identified by both T7EndonucleaseI digestion and sequencing.
  3. 3Representative results from experiment 3 are shown in Figure 2B and C.